Imagine discovering that a widely used contraceptive might be linked to a devastating health condition. That’s the alarming concern now facing thousands of women who developed brain tumors after using Depo-Provera, a popular contraceptive injection. But here’s where it gets controversial: while the overall risk remains low, multiple studies have shown that women using this high-dose synthetic progesterone face a significantly higher relative risk of developing meningiomas—benign tumors that can cause seizures, blindness, hearing loss, and memory problems. Now, UK law firms are gearing up to take action against pharmaceutical giant Pfizer, echoing similar lawsuits already underway in the US.
Depo-Provera, administered via injection every three months, is a go-to option for millions of women worldwide. According to UN data, 74 million women globally and 3.1% of UK women aged 15-49 rely on injectable contraception like this. It’s prescribed not only for birth control but also to manage menstrual symptoms. Yet, the potential link to meningiomas has sparked a fierce debate about patient safety and corporate responsibility.
And this is the part most people miss: Pfizer has known about the potential risk of meningioma since at least 2015, according to US lawsuits, but critics argue the company failed to adequately warn patients, doctors, or regulators. Pfizer denies liability, emphasizing its rigorous safety monitoring and the drug’s approval in over 60 countries over three decades. But for women like Sandra Somarakis, who developed a meningioma after 15 years of using Depo-Provera, the consequences are life-altering. ‘Women shouldn’t have to live with what I’ve gone through,’ she says. ‘There has to be consequences.’
In the UK, law firms like Austen Hays, Fletchers, and Leigh Day are now investigating potential claims. Chaya Hanoomanjee of Austen Hays notes that at least 30 women have come forward, many suffering severe impacts like vision loss or even pregnancy termination due to the tumors. ‘Pfizer has a duty to ensure their drug is safe and to update warnings as new risks emerge,’ she argues. Meanwhile, Jill Paterson of Leigh Day stresses the devastating impact meningiomas can have on women’s lives, calling for a thorough assessment of potential legal claims.
The stories are heart-wrenching. Claire Buck, 47, from Surrey, believes the injection contributed to her meningioma, which required brain surgery and left her with a metal plate in her head. ‘I nearly died,’ she recalls. ‘I’m lucky to be here.’ Emma (a pseudonym), 57, who took Depo-Provera for 15 years, now struggles with fatigue and memory issues after her diagnosis in 2024. Both women worry about the long-term prognosis and fear the tumors could return.
Here’s the burning question: Should pharmaceutical companies like Pfizer be held accountable for not acting sooner on potential risks? Or is the responsibility on patients and doctors to weigh the benefits against the rare but serious side effects? As the legal battles unfold in both the UK and US, one thing is clear: this issue demands attention, transparency, and action. What do you think? Share your thoughts in the comments below—this conversation is far from over.
